Most Doctors Don’t Know This Birth Control Option Exists, and It’s Been Available for 20 Years

A study reveals that many clinicians remain unaware of self-administered injectable contraception, despite its decades-long availability. Self-administered injectable contraceptives have been an ...

Rallybio’s Phase 2 FNAIT Prevention Study Reaches Completion: What Investors Should Watch Next

Rallybio Corporation (RLYB) announced an update on their ongoing clinical study.
Le Lézard

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...